STEVEN REEDY: Open Payments
NPI 1477137800 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 39 payments from 5 companies in 2025. Trend: 2023 $281 · 2024 $475 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $208 |
| ABBVIE INC. | 24 | $202 |
| Janssen Pharmaceuticals, Inc | 4 | $190 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, INVEGA SUSTENNA, INGREZZA, UZEDY.
Industry payments across OH — which companies pay providers there.
